1. Home
  2. TENX vs BRLT Comparison

TENX vs BRLT Comparison

Compare TENX & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • BRLT
  • Stock Information
  • Founded
  • TENX 1967
  • BRLT 2005
  • Country
  • TENX United States
  • BRLT United States
  • Employees
  • TENX N/A
  • BRLT N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • BRLT Consumer Specialties
  • Sector
  • TENX Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • TENX 21.6M
  • BRLT 22.4M
  • IPO Year
  • TENX N/A
  • BRLT 2021
  • Fundamental
  • Price
  • TENX $5.90
  • BRLT $1.46
  • Analyst Decision
  • TENX Strong Buy
  • BRLT Hold
  • Analyst Count
  • TENX 3
  • BRLT 3
  • Target Price
  • TENX $16.00
  • BRLT $1.80
  • AVG Volume (30 Days)
  • TENX 40.6K
  • BRLT 37.4K
  • Earning Date
  • TENX 08-12-2025
  • BRLT 08-07-2025
  • Dividend Yield
  • TENX N/A
  • BRLT N/A
  • EPS Growth
  • TENX N/A
  • BRLT N/A
  • EPS
  • TENX N/A
  • BRLT N/A
  • Revenue
  • TENX N/A
  • BRLT $418,708,000.00
  • Revenue This Year
  • TENX N/A
  • BRLT $3.79
  • Revenue Next Year
  • TENX N/A
  • BRLT $3.85
  • P/E Ratio
  • TENX N/A
  • BRLT N/A
  • Revenue Growth
  • TENX N/A
  • BRLT N/A
  • 52 Week Low
  • TENX $2.80
  • BRLT $1.25
  • 52 Week High
  • TENX $7.89
  • BRLT $2.68
  • Technical
  • Relative Strength Index (RSI)
  • TENX 53.10
  • BRLT 54.43
  • Support Level
  • TENX $5.77
  • BRLT $1.47
  • Resistance Level
  • TENX $5.96
  • BRLT $1.60
  • Average True Range (ATR)
  • TENX 0.32
  • BRLT 0.06
  • MACD
  • TENX 0.01
  • BRLT 0.01
  • Stochastic Oscillator
  • TENX 26.98
  • BRLT 41.90

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: